| Document |
Document Title |
|
WO/2020/248943A1 |
The present application provides a nitrogen-containing compound, an electronic component and an electronic device, and belongs to the technical field of organic materials. The structure of the nitrogen-containing compound is as shown in ...
|
|
WO/2020/252240A1 |
This disclosure features chemical entities (e.g., a compound or a pharmaceutically acceptable salt, and/or hydrate, and/or cocrystal, and/or drug combination of the compound) that inhibit (e.g., antagonize) Stimulator of Interferon Genes...
|
|
WO/2020/244323A1 |
Disclosed are a preparation method for a cis-p-mentha-1,8-secondary amine compound and a herbicidal application thereof. The method comprises: using a cis-p-mentha-1,8-di-schiff base compound as a raw material, putting reducing agents in...
|
|
WO/2020/245288A1 |
The invention pertains to a process for producing 5-hydroxymethylfurfural (HMF) comprising a) a step of converting a carbohydrate into HMF, the converting step comprising providing a reaction medium comprising carbohydrate, catalyst, wat...
|
|
WO/2020/241826A1 |
The present invention provides a compound that further improves the performance of organic EL elements, an organic electroluminescent element having further improved element performance, and an electronic device including such organic el...
|
|
WO/2020/240178A1 |
A compound, e.g. a diamine ligand, represented by the following general formula (1): (Formula (1)) wherein each * represents an asymmetric carbon atom; X represents a group selected from one of an ester (e.g. a t-butyl ester); a thioeste...
|
|
WO/2020/238559A1 |
Disclosed are a de-C2-symmetric diphenylamine-type chiral bisoxazoline ligand as shown in formula 3, a synthesis method therefor and the use thereof in an asymmetric catalytic reaction. The C2-symmetry of the ligand is removed by introdu...
|
|
WO/2020/238862A1 |
The present invention provides a fluorene initiator, a photocurable composition comprising same, and an application thereof. The fluorene photoinitiator has a structure represented by formula (I) or formula (II). In the photoinitiator, o...
|
|
WO/2020/238529A1 |
Disclosed by the present invention are a parecoxib impurity reference substance and a preparation method therefor. The parecoxib impurity reference substance has a structure as described in formula II. The preparation method comprises th...
|
|
WO/2020/237835A1 |
Disclosed are a spirobifluorene organic light-emitting compound and an organic light-emitting device. The spirobifluorene organic light-emitting compound has a structural formula as shown in formula I. Such a compound can be used as an o...
|
|
WO/2020/233512A1 |
An aromatic amine androgen receptor (AR) and BET targeting protein degradation chimera compound and use. Specifically provided is a compound represented by formula I. Experimental results show that the compound can target and degrade bot...
|
|
WO/2020/185054A9 |
The present invention provides a novel compound and an organic light emitting device using same.
|
|
WO/2020/234303A1 |
A process for the production of furfural from a biphasic composition including furfural, an organic solvent and soluble organic debris. The said process includes subjecting the biphasic composition to a liquid-liquid separation step to p...
|
|
WO/2020/229158A1 |
A furan-based surfactant comprising a beta sulphonate head group, a furan and a C10-20 hydrophobic group which is either attached directly to the furan or by way of a linker. A laundry composition or a hand dish wash cleaning composition...
|
|
WO/2020/230833A1 |
The purpose of the present invention is to provide a novel compound which has the action of effectively enhancing the antifungal activity of an antifungal drug and which has a skeleton structure different from that of known pharmaceutica...
|
|
WO/2020/225569A1 |
The present invention relates to a compound of formula (I), or a pharmaceutically acceptable salt or hydrate thereof, wherein: the group X-Y is -NHSO2- or -SO2NH-; Z is a monocyclic aryl or heteroaryl group, each of which is optionally s...
|
|
WO/2020/220942A1 |
A compound, an organic electroluminescent device containing the compound, and an application thereof. The compound has a structure shown in (I).
|
|
WO/2020/222010A1 |
The invention relates to compounds of formula (I) and to their use in treating or preventing an inflammatory disease or a disease associated with an undesirable immune response: (I) wherein R A, R B, R C and R D are as defined herein.
|
|
WO/2020/220651A1 |
Disclosed are a method for synthesizing a chiral 2-hydroxy-1,4-dicarbonyl compound by using a tetrapeptide TP or an enantiomer ent-TP thereof as a chiral catalyst to catalyze an asymmetric Aldol reaction between fatty aldehyde and glyoxy...
|
|
WO/2020/220562A1 |
A benzofuran-6-formamide derivative having a structure represented by formula (I), a preparation method therefor, and a pharmaceutical application thereof. The definition of each substituent is as described in the description and the cla...
|
|
WO/2020/223536A1 |
Provided herein are compounds, compositions, and methods useful for modulating the integrated stress response (ISR) and for treating related diseases, disorders and conditions.
|
|
WO/2020/216701A1 |
The present invention provides acyl sulfonamide compounds of general formula (I): in which X, R1, R2, R3, R4, R5, R6, Ra and Rb are as described and defined herein, methods of preparing said compounds, intermediate compounds useful for p...
|
|
WO/2020/218515A1 |
This compound is represented by general formula (1). In the formula, at least one of R11 to R18 represents a substituted or unsubstituted phenyl group, a substituted or unsubstituted biphenyl group or a substituted or unsubstituted terph...
|
|
WO/2020/218514A1 |
A compound represented by general formula (1). In the formula, at least one of R11 to R18 represents a substituted or unsubstituted phenyl group, a substituted or unsubstituted biphenyl group or a substituted or unsubstituted terphenyl g...
|
|
WO/2020/217209A1 |
The invention provides a method for depolymerising a phenolic polymer, the method comprising reacting the phenolic polymer with dimethylsulphoxide (DMSO) and a hydrogen halide. The phenolic polymer may be selected from the group consisti...
|
|
WO/2020/215812A1 |
Provided in the present invention is a method for preparing 4,4'-dialkylbiphenyl from 2-alkyl furan. The method comprises a two-step reaction: (1) a 5,5'-dialkyl-2,2'-bifuran compound is prepared from 2-alkyl furan, a catalyst used for t...
|
|
WO/2020/216298A1 |
Disclosed are a compound as shown in formula I, a stereoisomer thereof, and a pharmaceutically acceptable salt thereof. The present invention also relates to a pharmaceutical composition containing the compound of formula I and use of th...
|
|
WO/2020/218134A1 |
The present invention addresses the problem of providing an industrially advantageous production method with high purity and high yield, which has an improved reaction selectivity for a tetracarboxylic acid dianhydride that has, as a mai...
|
|
WO/2020/218187A1 |
An organic electroluminescent element which comprises a light emitting layer between a positive electrode and a negative electrode facing each other, and which is characterized in that: the light emitting layer contains a first host, a s...
|
|
WO/2020/214419A1 |
Novel processes for recovering solvents and isolating humin or humate materials from 5-hydroxymethylfurfural (HMF) and 2,5-furandicarboxylic acid (FDCA) pathway processes are described. In some embodiments, the process utilizes a thin fi...
|
|
WO/2020/213460A1 |
Provided is an ink composition for producing an organic semiconductor device, wherein an organic semiconductor material having a rigid main-chain backbone can be made into an ink with a solute concentration most suitable for a single-cry...
|
|
WO/2020/211668A1 |
Disclosed are compounds that are inhibitors of CD73 and are useful in treating CD73-associated diseases or conditions, and compositions containing the compounds.
|
|
WO/2020/212041A1 |
The present invention is directed to a monomer for chain growth polymerization, in particular anionic polymerization, said monomer having the general formula (EFL) wherein: Ra is a C3-C30 alkyl, C3-C30 cycloalkyl, C6-C18 aryl or C2-C12 a...
|
|
WO/2020/209292A1 |
An organic electroluminescent element which comprises a cathode, an anode, and a luminescent layer disposed between the cathode and the anode, wherein the luminescent layer comprises a compound represented by formula (1) and one or more ...
|
|
WO/2020/209293A1 |
An organic electroluminescent element includes a cathode, an anode, and an organic layer disposed between the cathode and the anode, wherein the organic layer includes a light-emitting layer and a first layer, the first layer is disposed...
|
|
WO/2020/209035A1 |
A compound represented by formula (1). R1 is, for example, an alkyl having 1-15 carbon atoms; ring A1 and ring A2 are 1,4-phenylene, etc.; a is 2, etc.; b and c are 0, 1, or 2; Z1 is a single bond, etc.; P1 and P2 are polymerizable group...
|
|
WO/2020/210396A1 |
Systems and methods include providing a gaseous alkane input stream and metal sulfide (MSx) particles that can react with an alkane in the gaseous alkane input stream to generate an alkene, a reduced metal sulfide (MSx-1) particle, and a...
|
|
WO/2020/209299A1 |
An organic electroluminescent element comprising a cathode, an anode, and an organic layer disposed between the cathode and the anode, wherein the organic layer comprises a light-emitting layer and a first layer, the first layer is dispo...
|
|
WO/2020/209307A1 |
An organic electroluminescent element which comprises a negative electrode, a positive electrode and a light emitting layer that is arranged between the negative electrode and the positive electrode, wherein the light emitting layer cont...
|
|
WO/2020/199945A1 |
The present invention relates to the technical field of medicine, and discloses a compound as shown in formula (I) and a preparation method therefor, a pharmaceutical composition and the use thereof. In particular, further disclosed in t...
|
|
WO/2020/201610A1 |
The present invention relates to the spiro-heterocyclic compounds of general formula (I), wherein: n is selected from 0, 1 and 2; G is selected from C and N; A is a heteroatom selected from O, S, N, NH and NRi, wherein Ri is selected fro...
|
|
WO/2020/199568A1 |
Disclosed is a compound "Ginkgo biloba root acid", which is separated from root bark of Ginkgo biloba, i.e., 1,8-dyhydroxyl-dibenzofuran-2,6-dicarboxylic acid, the molecular formula thereof being C14H8O7. Also disclosed is a method for e...
|
|
WO/2020/205470A1 |
The present disclosure provides compounds and methods for inhibiting or degrading the N-terminal domain of the androgen receptor, as well as methods for treating cancers such as prostate cancer.
|
|
WO/2020/202777A1 |
[Problem] To provide an epoxy curing compound that makes it possible to obtain an epoxy resin composition having high heat resistance, flexibility, water resistance, and transparency. [Solution] An epoxy curing compound characterized by ...
|
|
WO/2020/195437A1 |
The present invention provides a method for producing a compound represented by formula (1a), (1b) or (1c), the method including a step in which a compound represented by formula (3) is reduced to obtain a compound represented by formula...
|
|
WO/2020/192053A1 |
Provided is a method for preparing furfural. The method comprises: mixing a plant raw material and an acid containing a -SO3H functional group for pre-treating, then mixing same with an organic acid, cooking same, and then subjecting sam...
|
|
WO/2020/196459A1 |
This 3-hydroxyadipic acid-3,6-lactone production method enables easy recovery of, from a 3-hydroxyadipic acid-containing aqueous solution, 3-hydroxyadipic acid-3,6-lactone, which is a material for synthesizing ε-caprolactam, the method ...
|
|
WO/2020/191091A1 |
This invention provides for compounds of the formula wherein the variables are defined herein, or a stereoisomer, tautomer, N-oxide, hydrate, solvate, or salt thereof, compositions comprising these compounds, and method for the treatment...
|
|
WO/2020/189316A1 |
A compound according to the present invention, which is represented by formula (A) enables the achievement of an organic electroluminescent element that has more improved element performance. (In the formula, Ar, R1-R7, R11-R14, R21-R24,...
|
|
WO/2020/186421A1 |
Disclosed are a coordinate zirconium phosphotungstate catalyst and the use thereof in the catalytic hydrogenation of furfural, belonging to the field of heterogeneous catalysis. The zirconium phosphotungstate catalyst obtained in the pre...
|
